Marlins catcher Ronny Paulino suspended 50 games for PEDs

14 Comments

Joel Sherman of the New York Post reports that Marlins catcher Ronny Paulino has been suspended 50 games after testing positive for a performance-enhancing drug.

Numerous minor leaguers have been suspended for PED usage this year, but Paulino and Edinson Volquez are the only major leaguers to get the 50-game ban. Last season Manny Ramirez and J.C. Romero were two big leaguers suspended.

Paulino began this season as the Marlins’ backup catcher, but was forced into the lineup thanks to John Baker’s elbow injury and has started 84 of the team’s 120 games while hitting .259/.311/.354 with four homers in 344 plate appearances.

Baker is slated to return from the disabled list by the end of this month and in the meantime the Marlins will likely lean on 26-year-old rookie Brett Hayes as their primary backstop. And because there are only 42 games remaining on the Marlins’ schedule, Paulino’s suspension will carry over to the first eight games of next season.

UPDATE: Paulino issued a statement saying that he tested positive for “a dietary pill” used “to control my weight this season.” He also apologized:

I recently learned that the dietary pill contained a substance banned under Major League Baseball’s drug policy. I am ashamed and saddened for disappointing and distracting my family, my teammates, the entire Florida Marlins’ organization, and baseball fans. My heartfelt and most sincere apology.

I accept full responsibility and all consequences for this mistake and therefore, choose not to challenge my suspension. I was irresponsible for failing to take all precautionary steps in confirming the approval of the dietary pill. Without a doubt, I have learned from my mistake.

I know we’ll all sleep better tonight knowing Ronny Paulino and his gut are off the street. Or something.

Danny Espinosa reportedly skipped Nationals Winterfest because of Adam Eaton

WASHINGTON, DC - OCTOBER 13: Danny Espinosa #8 of the Washington Nationals celebrates after teammate Chris Heisey #14 (not pictured) hits a two run home run in the seventh inning against the Los Angeles Dodgers during game five of the National League Division Series at Nationals Park on October 13, 2016 in Washington, DC. (Photo by Rob Carr/Getty Images)
Getty Images
5 Comments

According to Jorge Castillo of the Washington Post, Nationals infielder Danny Espinosa declined to attend the team’s annual Winterfest because of his dissatisfaction with management following their trade for outfielder Adam Eaton.

A source told Castillo that Espinosa’s unhappiness stemmed from a belief that the acquisition would jeopardize his starting role in 2017. With Eaton in center field, Trea Turner will likely return to his post at shortstop, leaving Espinosa out in the cold — or, as the case may be, on the bench. The move shouldn’t come as a big surprise to Espinosa, however, as Nationals’ GM Mike Rizzo spoke to the possibility of trading the infielder or reassigning him to a utility role back in early November.

Offensively, the 29-year-old had a down year in 2016, slashing just .209/.306/.378 with 24 home runs in 601 PA. Defensively, he still profiles among the top shortstops in the National League, with eight DRS (Defensive Runs Saved) and 8.3 Def (Defensive Runs Above Average) in his seventh year with the club.

Espinosa will reach free agency after the 2017 season.

Nick Cafardo: Red Sox should deal Pomeranz, not Buchholz

BOSTON, MA - SEPTEMBER 18: Drew Pomeranz #31 of the Boston Red Sox pitches during the first inning against the New York Yankees at Fenway Park on September 18, 2016 in Boston, Massachusetts. The Red Sox won 5-4. (Photo by Rich Gagnon/Getty Images)
Getty Images
9 Comments

The Red Sox might be trying to move the wrong pitcher, according to the Boston Globe’s Nick Cafardo. Cafardo revealed that while the Sox have been trying to market right-hander Clay Buchholz, more teams would be interested in trades involving southpaw Drew Pomeranz.

The club appears reluctant to deal Pomeranz, especially because his price tag comes in at a cool $4.7 million to Buchholz’s $13.5 million in 2017. Those who have already expressed interest in the veteran hurlers, including the Twins, Mariners and Royals, also seem put off by Buchholz’s salary requirements as he enters his 32nd year.

Health could be another factor preventing teams from jumping to make trade offers, as Cafardo quotes an AL executive who believes the “medicals on both Pomeranz and Buchholz probably aren’t that great.” Neither pitcher suffered any major injuries during the 2016 season, though Pomeranz missed just over a week of play due to forearm soreness.

Pomeranz outperformed his fellow starter in 2016, pitching to a 3.32 ERA and career-best 9.8 K/9 through 170 2/3 innings with the Padres and Red Sox. He got off to an exceptionally strong start in San Diego, where his ERA dropped to 2.47 through the first half of the year before the Padres dealt him to Boston for minor league right-hander Anderson Espinoza. Buchholz, on the other hand, struggled with a 4.78 ERA and saw a decline in both his BB/9 and K/9 rates as he worked out a career-low 1.69 K/BB through 139 1/3 innings with the Sox.